Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

Targeted lung cancer drug shows promise in phase I/II clinical trial

Targeted lung cancer drug shows promise in phase I/II clinical trial

AKT inhibitor shows signs of effectiveness in a patient trial matching drugs to tumour gene mutations

AKT inhibitor shows signs of effectiveness in a patient trial matching drugs to tumour gene mutations

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

Scientists pinpoint druggable target in aggressive breast cancer

Scientists pinpoint druggable target in aggressive breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Liquid biopsies can detect which cancer patients may be at higher risk of developing additional blood cancers

Liquid biopsies can detect which cancer patients may be at higher risk of developing additional blood cancers

$FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma$

FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

AI model using daily step counts predicts unplanned hospitalisations during cancer therapy

AI model using daily step counts predicts unplanned hospitalisations during cancer therapy

Radiation-hormone therapy combination may slow growth of oligometastatic prostate cancer

Radiation-hormone therapy combination may slow growth of oligometastatic prostate cancer

More from ecancer